NCT05564819

Brief Summary

Pain will bring early and long-term adverse reactions to infants. The investigators need to pay attention to whether there is pain in infants after surgery. Since infants cannot self-report pain,The investigators need to use appropriate pain assessment scale to evaluate the pain of these infants, so as to understand the status of postoperative pain in children. The result of pain score not only enables investigators to understand the pain status of children, but also helps investigators to give corresponding intervention and treatment according to the pain degree of children. Postoperative pain management is one of the core contents of ERAS. Effective pain management is beneficial to the early postoperative recovery of infants and reduces the adverse reactions caused by pain. Sveral studies have confirmed that the combination of acetaminophen and opioids could reduce the use of opioids after surgery. But even if opioid use is reduced, it still causes many side effects for children. This study evaluated the safety and efficacy of acetaminophen alone for postoperative analgesia in infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2022

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 4, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

July 10, 2024

Status Verified

July 1, 2024

Enrollment Period

8 months

First QC Date

September 16, 2022

Last Update Submit

July 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Using CRIES scale to assess the pain level at 12 hours after postoperative awakening

    The pain score was evaluated 12 hours after Children wake up

    12 hours after postoperative awakening

Secondary Outcomes (23)

  • liver function

    48 hours after surgery

  • renal function

    48 hours after surgery

  • LOS

    30 days after surgery

  • Using CRIES scale to assess the pain level at 1 hour after postoperative awakening

    1 hour after postoperative awakening

  • Using CRIES scale to assess the pain level at 6 hours after postoperative awakening

    6 hours after postoperative awakening

  • +18 more secondary outcomes

Study Arms (2)

Treatment group

EXPERIMENTAL

After recovering and returning to the ward, acetaminophen (10mg/kg) was taken orally immediately; once every 6 hours, a total of 4 times.

Drug: Acetaminophen

placebo group

PLACEBO COMPARATOR

The same amount of sterilized water was administered orally at the same time points.

Drug: Sterilized water

Interventions

When the infants woke up after surgery and were transported back to the ward, they were randomly divided into two groups immediately. The intervention group was given oral acetaminophen, once every 6 hours, for a total of 4 times.

Treatment group

When the infants woke up after surgery and were transported back to the ward, they were randomly divided into two groups immediately. The control group was given sterilized water, once every 6 hours, for a total of 4 times.

placebo group

Eligibility Criteria

Age1 Day - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Informed consent was obtained from parents of children;
  • Infants aged 0-12 months;
  • Children who underwent abdominal and perineal surgery in the Department of Neonatal Surgery, Children's Hospital Affiliated to Nanjing Medical University and returned to the unaccompanied ward after removal of tracheal intubation.

You may not qualify if:

  • No informed consent was obtained from parents;
  • known allergy or intolerance to acetaminophen;
  • Children with liver function impairment (alanine aminotransferase/aspartate aminotransferase (ALAT/ASAT) more than three times the reference value;
  • Children with renal insufficiency (urea and creatinine values exceeding the upper limit of reference values);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210008, China

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Acetaminophen

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Department of neonatal surgery

Study Record Dates

First Submitted

September 16, 2022

First Posted

October 4, 2022

Study Start

September 14, 2022

Primary Completion

May 15, 2023

Study Completion

July 31, 2023

Last Updated

July 10, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Locations